Inventor · disambiguated record
Henrik Clausen
Also filed as: CLAUSEN HENRIK · CLAUSEN HENRIK SAABY
67 granted patents·21 pending applications·914 citations·filing 1987–2023
99Inventor score
Top patents by PatentIndex Score
88 records- 0198USD614247SElement of a construction setLEGO AS·Filed 2009·Granted Apr 20, 2010·55 cites·1 claims
- 0298US7338933B2O-linked glycosylation of peptidesNEOSE TECHNOLOGIES INC·Filed 2005·Granted Mar 4, 2008·111 cites·20 claims
- 0395US8440798B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesCLAUSEN HENRIK·Filed 2007·Granted May 14, 2013·67 cites·6 claims
- 0495US8361961B2O-linked glycosylation of peptidesBIOGENERIX AG·Filed 2005·Granted Jan 29, 2013·37 cites·15 claims
- 0593US7932364B2Compositions and methods for the preparation of human growth hormone glycosylation mutantsNOVO NORDISK AS·Filed 2004·Granted Apr 26, 2011·45 cites·33 claims
- 0692US8052667B2Apparatus for prolonging survival of plateletsVELICO MEDICAL INC·Filed 2005·Granted Nov 8, 2011·15 cites·22 claims
- 0791US8268967B2Glycopegylated interferon αDEFREES SHAWN·Filed 2005·Granted Sep 18, 2012·24 cites·31 claims
- 0889US8912311B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesKØBENHAVNS UNI·Filed 2013·Granted Dec 16, 2014·8 cites·4 claims
- 0987US10919973B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesUNIV COPENHAGEN·Filed 2018·Granted Feb 16, 2021·2 cites·11 claims
- 1087US8221745B2Prolonging survival of platelets using CMP-sialic acid,UDP-galactose or bothROSIELLO KEITH M·Filed 2008·Granted Jul 17, 2012·4 cites·25 claims
- 1186US9359436B2Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodiesKØBENHAVNS UNI·Filed 2014·Granted Jun 7, 2016·4 cites·8 claims
- 1286US7858295B2Methods for prolonging survival of platelets using UDP-galactoseVELICO MEDICAL INC·Filed 2007·Granted Dec 28, 2010·7 cites·15 claims
- 1384US11708569B2Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acidUNIV COPENHAGEN·Filed 2019·Granted Jul 25, 2023·4 cites·6 claims
- 1484US10139414B2Tn-MUC4 binding polypeptides and uses thereofGO THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·4 cites·28 claims
- 1584US6635461B1UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3GLYCOZYM APS·Filed 2000·Granted Oct 21, 2003·17 cites·24 claims
- 1684US5229289AMonoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugatesBIOMEMBRANE INST·Filed 1991·Granted Jul 20, 1993·68 cites·4 claims
- 1783US9029331B2Glycopegylated granulocyte colony stimulating factorDEFREES SHAWN·Filed 2006·Granted May 12, 2015·3 cites·4 claims
- 1883US7241282B2Compositions and methods for prolonging survival of plateletsZYMEQUEST INC·Filed 2003·Granted Jul 10, 2007·15 cites·5 claims
- 1983US5326857AABO genotypingBIOMEMBRANE INST·Filed 1991·Granted Jul 5, 1994·50 cites·30 claims
- 2082US11067578B2Tn-MUC4 binding polypeptides and uses thereofGO THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·1 cites·26 claims
- 2182US8517967B2Methods of using an apparatus for prolonging survival of platelets using CMP-sialic acid, UDP-galactose or bothROSIELLO KEITH·Filed 2011·Granted Aug 27, 2013·7 cites·17 claims
- 2281US5421733ASynthesis of Lex ; dimeric Lex (difucosyl Y2 ; III3 FucV3 FucnLc6 Cer); sialylated forms thereof; and analogues thereofBIOMEMBRANE INST·Filed 1991·Granted Jun 6, 1995·22 cites·10 claims
- 2380US7115404B2UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1GLYCOZYM APS·Filed 2002·Granted Oct 3, 2006·6 cites·7 claims
- 2479US7993896B2Streptomyces griseoplanus α-galactosidases for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cellsVELICO MEDICAL INC·Filed 2010·Granted Aug 9, 2011·1 cites·2 claims
- 2577US7374919B2UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2GLYCOZYM APS·Filed 2005·Granted May 20, 2008·1 cites·5 claims
- 2677US6465220B1Glycosylation using GalNac-T4 transferaseGLYCOZYM APS·Filed 1998·Granted Oct 15, 2002·53 cites·4 claims
- 2776USD641054SElement of a construction set toyLEGO AS·Filed 2010·Granted Jul 5, 2011·12 cites·1 claims
- 2876US5660834AMonoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugatesBIOMEMBRANE INST·Filed 1995·Granted Aug 26, 1997·49 cites·14 claims
- 2976US5240833AMethod for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosidesBIOMEMBRANE INST·Filed 1991·Granted Aug 31, 1993·49 cites·2 claims
- 3075US12325871B2Lysosomal enzymes modified by cell based glycoengineeringUNIV COPENHAGEN·Filed 2023·Granted Jun 10, 2025·0 cites·13 claims
- 3175US11860165B2CORE3-MUC1 binding polypeptides and uses thereofGO THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·26 claims
- 3274US7951552B2Method of preparing non-human tissues for xenotransplantation using α-galactosidaseVELICO MEDICAL INC·Filed 2006·Granted May 31, 2011·1 cites·2 claims
- 3374US7767415B2Compositions and methods for modifying blood cell carbohydratesVELICO MEDICAL INC·Filed 2002·Granted Aug 3, 2010·3 cites·4 claims
- 3474US7449316B2UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1GLYCOZYM APS·Filed 2005·Granted Nov 11, 2008·1 cites·11 claims
- 3574US6916649B2UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2GLYCOZYM APS·Filed 2002·Granted Jul 12, 2005·2 cites·6 claims
- 3672US7332279B2UDP-galactose: β-N-acetyl-glucosamine β1,3 galactosyltransferases, β3gal-T5GLYCOZYM APS·Filed 2004·Granted Feb 19, 2008·3 cites·4 claims
- 3771US9588121B2Method for early detection of cancerWANDALL HANS H·Filed 2010·Granted Mar 7, 2017·5 cites·7 claims
- 3871US8697411B2Streptomyces griseoplanus comprising an α-galactosidase for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cellsCLAUSEN HENRIK·Filed 2011·Granted Apr 15, 2014·1 cites·4 claims
- 3970US5871990AUDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase, gAlnAc-T3Filed 1996·Granted Feb 16, 1999·33 cites·28 claims
- 4070US5747048AMonoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugatesBIOMEMBRANE INST·Filed 1994·Granted May 5, 1998·33 cites·9 claims
- 4169US7670816B2UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1GLYCOZYM USA INC·Filed 2008·Granted Mar 2, 2010·1 cites·10 claims
- 4269US5068191APurified histo-blood group a glycosyltransferase and antibodies theretoBIOMEMBRANE INST·Filed 1989·Granted Nov 26, 1991·27 cites·8 claims
- 4368USD630272STrack elementLEGO AS·Filed 2009·Granted Jan 4, 2011·6 cites·1 claims
- 4468US7771978B2β1,4mannosyltransferasesCLAUSEN HENRIK·Filed 2004·Granted Aug 10, 2010·2 cites·10 claims
- 4567US2008038809A1ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASESGLYCOZYM APS·Filed 2007·Application pending·0 cites
- 4665US7078206B2UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1,6N-acetylglucosaminyltransferase, C2GnT3GLYCOZYM APS·Filed 2004·Granted Jul 18, 2006·0 cites·4 claims
- 4764USD630270STrack elementLEGO AS·Filed 2009·Granted Jan 4, 2011·5 cites·1 claims
- 4864US6794169B2UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R / (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3GLYCOZYM APS·Filed 2002·Granted Sep 21, 2004·1 cites·10 claims
- 4964US2021095317A1N-GlycosylationUNIV COPENHAGEN·Filed 2020·Application pending·0 cites
- 5064US2021087587A1N-GlycosylationUNIV COPENHAGEN·Filed 2020·Application pending·0 cites
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Henrik Clausen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →